A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Recruiting

HPV VaccineA Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Sponsor:

University of British Columbia

Code:

NCT05495906

Conditions

HPV

Human Papilloma Virus

Human Immunodeficiency Virus

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Accepted

Interventions

Nonavalent HPV vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University of British Columbia on 2025-03-27.